Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lamotrigine Formulations in Healthy Chinese Males
NCT02064465Phase 1Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lamotrigine in epilepsy (2 arms), sponsored by GSK. Primary endpoints: Area under the concentration-time curve from time zero to infinity and Maximum serum drug concentration. Started Mar 2014; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02064465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02064465.